Research graph
References from Calcium dysregulation in synergy with sonodynamic therapy via medroxyprogesterone-targeted and ROS-responsive nanoparticles for endometrial cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Trends in the incidence of endometrial cancer among young women in the United States, 2001 to 2017
2021 · External reference
Evaluation and clinical considerations for fertility-sparing treatment in young patients with early-stage endometrial cancer
2025 · External reference
Progestin resistance and corresponding management of abnormal endometrial hyperplasia and endometrial carcinoma
10.3390/cancers14246210 · 2022 · External reference
Advances in the molecular mechanisms underlying progestin resistance in endometrial cancer
10.1016/j.fmre.2023.07.008 · 2025 · External reference
Calcium and calcium-related proteins in endometrial cancer: opportunities for pharmacological intervention
10.7150/ijbs.68591 · 2022 · External reference
The role of oestrogen and oestrogen-calcium axis in endometrial carcinoma
2024 · External reference
Estrogen-induced extracellular calcium influx promotes endometrial cancer progress by regulating lysosomal activity and mitochondrial ROS
10.3389/fmed.2022.835700 · 2022 · External reference
The L-type calcium channel CaV1.3: a potential target for cancer therapy
10.1111/jcmm.70123 · 2024 · External reference
Azelnidipine nanoparticles break calcium homeostasis and induce severe ER stress combined with medroxyprogesterone acetate for endometrial cancer therapy
10.1016/j.nantod.2022.101682 · 2022 · External reference
Calcium and TRPV4 promote metastasis by regulating cytoskeleton through the RhoA/ROCK1 pathway in endometrial cancer
10.1038/s41419-020-03181-7 · 2020 · External reference
Effects of TRPV2 on the expression of PD-L1 and its binding ability to PD-1 in gastric cancer
10.1245/s10434-023-14084-0 · 2023 · External reference
Calcium channel blocker Lacidipine promotes antitumor immunity by reprogramming tryptophan metabolism
10.1002/advs.202409310 · 2025 · External reference
Pharmacokinetic insights and therapeutic potential of calcium channel blockers in cardiovascular and non-cardiovascular disorders
10.2174/0113816128420831251215100833 · 2026 · External reference
Targeting T-type channels in cancer: what is on and what is off?
10.1016/j.drudis.2021.11.021 · 2022 · External reference
STING-activating nanoplatforms for image-guided sonodynamic cancer therapy
10.1186/s12943-026-02591-z · 2026 · External reference
Cobalt(III) prodrug-based nanomedicine for inducing immunogenic cell death and enhancing chemo-immunotherapy
10.1016/j.jconrel.2024.07.042 · 2024 · External reference
Nanomedicine-enabled sonomechanical, sonopiezoelectric, sonodynamic, and sonothermal therapy
10.1002/adma.202212259 · 2023 · External reference
Ultrasound-responsive nanoparticles: modulating the tumor microenvironment to advance cancer immunotherapy
10.1016/j.celbio.2025.100255 · 2025 · External reference
ESGO/ESHRE/ESGE guidelines for the fertility-sparing treatment of patients with endometrial carcinoma
10.1136/ijgc-2022-004047 · 2023 · External reference
Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with αPD-L1 for enhanced cancer immunotherapy
2023 · External reference
Efficacy of chlorin e6-mediated sono-photodynamic therapy on 4T1 cells
2014 · External reference
Manidipine inhibits endothelin-1-induced [Ca2+]i signaling but potentiates endothelin's effect on c-fos and c-jun induction in vascular smooth muscle and glomerular mesangial cells
10.1016/0002-8703(93)90208-q · 1993 · External reference
Proteotoxic stress and the ubiquitin proteasome system
10.1016/j.semcdb.2023.08.002 · 2024 · External reference
Redox regulation of proteostasis
10.1016/j.jbc.2024.107977 · 2024 · External reference
Reversing adenosine-mediated immunosuppression in triple-negative breast cancer by synergistic chemo-immunotherapy via stimuli-responsive nanomedicines
10.1016/j.ebiom.2025.106059 · 2026 · External reference
Metabolic targeting of oxidative phosphorylation enhances chemosensitivity in triple-negative breast cancer via a synergistic nanomedicine
10.7150/thno.116250 · 2025 · External reference
Nanosensitizer-mediated augmentation of sonodynamic therapy efficacy and antitumor immunity
10.1038/s41467-023-42509-7 · 2023 · External reference
Metalloporphyrin MOFs-Based nanoagent enabling tumor microenvironment responsive sonodynamic therapy of intracranial glioma signaled by NIR-IIb luminescence imaging
10.1002/adfm.202307816 · 2024 · External reference
Exosome-inhibiting polymeric sonosensitizer for tumor-specific sonodynamic immunotherapy
10.1002/adma.202400762 · 2024 · External reference
γ-Glutamyl transpeptidase-activable nanoprobe crosses the blood-brain barrier for immuno-sonodynamic therapy of glioma
2024 · External reference
Charge separation engineering modulates self-oxygenating nano-heterojunctions to induce ferroptosis for sonodynamic-immunotherapy of tumors
10.1016/j.cej.2025.160713 · 2025 · External reference
The deadly connection between endoplasmic reticulum, Ca2+, protein synthesis, and the endoplasmic reticulum stress response in malignant glioma cells
10.1093/neuonc/nou012 · 2014 · External reference
Intelligent gold nanoparticles for synergistic tumor treatment via intracellular Ca2+ regulation and resulting on-demand photothermal therapy
10.1016/j.cej.2021.133850 · 2022 · External reference
Physiological overview of the potential link between the UPS and Ca2+ signaling
10.3390/antiox11050997 · 2022 · External reference
Nanoparticle-mediated TRPV1 channel blockade amplifies cancer thermo-immunotherapy via heat shock factor 1 modulation
10.1038/s41467-023-38128-x · 2023 · External reference
Manipulating calcium homeostasis with nanoplatforms for enhanced cancer therapy
10.1002/exp.20230019 · 2024 · External reference
Biomimetic and personalized nanovaccines in cancer immunotherapy: design innovations, translational challenges, and future directions
10.1016/j.jare.2026.01.070 · 2026 · External reference
Epigenetic regulation in cancer therapy: from mechanisms to clinical advances
10.1002/mog2.59 · 2024 · External reference
Persistent spatial immune responses in glioblastoma following oncolytic virus therapy
10.1016/j.cytogfr.2026.02.003 · 2026 · External reference
A novel Zinc(II) complex for sonodynamic therapy induces pyroptosis of breast cancer cells and enhances anti-tumor immune response
10.1002/advs.202508155 · 2025 · External reference
NO-Enhanced sonodynamic nanovesicles with Co-Stimulatory molecule self-presentation for multidimensional tumor immunotherapy
10.1002/anie.202504684 · 2025 · External reference
Glutathione-responsive metal–organic-framework-derived MnxOy/(A/R)TiO2 nanoparticles for enhanced synergistic sonodynamic/chemodynamic/immunotherapy
10.1021/acsnano.4c12304 · 2025 · External reference
Noninvasive activation of local and systemic immunity with a sequential-targeting sonodynamic nanovaccine to treat glioblastoma
10.1021/acsnano.5c08928 · 2025 · External reference
Sonodynamic-immunomodulatory nanostimulators activate pyroptosis and remodel tumor microenvironment for enhanced tumor immunotherapy
10.7150/thno.79945 · 2023 · External reference
Tumor microenvironment activated Cu crosslinked near-infrared sonosensitizers for visualized cuproptosis-enhanced sonodynamic cancer immunotherapy
10.1002/advs.202407196 · 2024 · External reference
Metabolic reprogramming nanomedicine potentiates colon cancer sonodynamic immunotherapy by inhibiting the CD39/CD73/ADO pathway
10.1016/j.apsb.2025.03.046 · 2025 · External reference
Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review
10.3802/jgo.2023.34.e49 · 2023 · External reference
Nanocarrier-based targeting of metabolic pathways for endometrial cancer: status and future perspectives
10.1016/j.biopha.2023.115348 · 2023 · External reference
Emerging drug delivery approach using nanomaterials for the treatment of endometrial cancer
10.3389/fmedt.2025.1680519 · 2025 · External reference
Preclinical evidence of sonodynamic therapy in glioblastoma and challenges towards clinical translation: a review of the literature
10.1038/s44384-026-00051-y · 2026 · External reference
Rationality of the FIGO2023 staging for early-stage endometrial cancer, compared with the FIGO2009 staging
2024 · External reference
Clinicopathological features, molecular mechanisms and prognosis of microcystic, elongated and fragmented (MELF) pattern in endometrial carcinoma: a review
2024 · External reference
